Date de publication: 11 août 2008
Promoteur – Intermédiaire Financier
BIA Separations Podjetje za separacijske tehnologije d.o.o.Lieu
Description
The project concerns the design, construction and equipment of the company’s new R&D and production facility and includes R&D activities related to the optimisation of purification processes for anti-viral (notably influenza, SARS) and DNA-based biopharmaceuticals by means of the company’s CIM-Technology, as well as to new, or improved anti-viral and biological detection and analysis methods.
Objectifs
The EIB loan under the RSFF scheme would provide co-financing of BIA Separations’ new R&D and production facilities as well as R&D activities.
Secteur(s)
Montant BEI envisagé (montant approximatif)
EUR 10 million.
Coût total (montant approximatif)
EUR 22 million.
Aspects environnementaux
The construction falls under Annex II of the Directive EU/97/11 amended by Directive 2003/35/EC on Environmental Impact Assessment. The competent authorities’ decision and argumentation for requesting an EIA will be verified during project appraisal.
Passation des marchés
The promoter is a private company, not operating in the Utilities sector and is thus not covered by EU Directives on procurement. The Bank services will however ascertain that procurement has been carried out in the best interest of the project.
Statut
Signé - 1/03/2009
Clause de non-responsabilité
Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).